BridgeBio Pharma (BBIO) Selling, General & Administrative (2018 - 2026)
BridgeBio Pharma's Selling, General & Administrative came in at $186.26 million for Q2 2026, up 44.2% from $129.15 million a year earlier and up 13.6% from the prior quarter.
Powered by 
Analysis
BridgeBio Pharma (BBIO) Selling, General & Administrative (2018 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, BridgeBio Pharma reported Selling, General & Administrative of $645.86 million, up 61.8% year-over-year; for FY2025, it was $531.23 million, up 83.9% from FY2024.
- Selling, General & Administrative has increased in each of the last three years, with a five-year compound annual growth rate of 29.5% (FY2020 to FY2025).
- Going back by year, Selling, General & Administrative was $288.93 million in FY2024 (+91.9%), $150.59 million in FY2023 (+5.2%), $143.19 million in FY2022 (-25.5%) and $192.21 million in FY2021 (+31.9%).
- The Q2 2026 figure represents the highest quarterly Selling, General & Administrative in data going back to Q2 2018.
- Year-over-year, Selling, General & Administrative has increased for 12 consecutive quarters, with growth averaging 79.4% over the last eight quarters.
- The fastest year-over-year change in Selling, General & Administrative over five years came in Q2 2025 (growth of 117.0%), and the weakest in Q4 2022 (a decline of 41.8%).
- Business Quant data shows BBIO's Selling, General & Administrative at $163.9 million (Q1 2026), $158.09 million (Q4 2025) and $137.62 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 6.43 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 3.63 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.90 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -3.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -5.65 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 1.75 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.92 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 3.41 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 582.20 Mn |
| 10 | BridgeBio Pharma | 12.85 Bn | 9.97 Bn | 228.63 Mn | 186.26 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 186.26 Mn |
| Mar 31, 2026 | 163.90 Mn |
| Dec 31, 2025 | 158.09 Mn |
| Sep 30, 2025 | 137.62 Mn |
| Jun 30, 2025 | 129.15 Mn |
| Mar 31, 2025 | 106.37 Mn |
| Dec 31, 2024 | 94.78 Mn |
| Sep 30, 2024 | 68.82 Mn |
| Jun 30, 2024 | 59.52 Mn |
| Mar 31, 2024 | 65.81 Mn |
| Dec 31, 2023 | 47.58 Mn |
| Sep 30, 2023 | 35.78 Mn |
| Jun 30, 2023 | 36.12 Mn |
| Mar 31, 2023 | 31.11 Mn |
| Dec 31, 2022 | 31.86 Mn |
| Sep 30, 2022 | 31.19 Mn |
| Jun 30, 2022 | 36.43 Mn |
| Mar 31, 2022 | 43.71 Mn |
| Dec 31, 2021 | 54.75 Mn |
| Sep 30, 2021 | 46.08 Mn |
API Access
BridgeBio Pharma Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=BBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "BBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=BBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();